Preamendment Class III devices
This article was originally published in The Gray Sheet
Executive Summary
FDA extends to Sept. 6 the comment period on its proposed schedule for calling for premarket approval applications for 117 preamendment Class III devices. The Health Industry Manufacturers Association had requested the 30-day extension